117 related articles for article (PubMed ID: 3321918)
21. Use of haloperidol decanoate in psychiatric diseases.
Zonda T; Kövári E
Ther Hung; 1992; 40(2):64-8. PubMed ID: 1361081
[TBL] [Abstract][Full Text] [Related]
22. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
23. A multicentre study on the efficacy and safety of individualized dosage of haloperidol (Haldol) in refractory chronic psychotics.
Nicodeme A; Vranckx-Haenen J; Wouters J
Acta Psychiatr Belg; 1977; 77(4):516-29. PubMed ID: 337756
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
25. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
26. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
[TBL] [Abstract][Full Text] [Related]
27. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy of haloperidol in chronic psychotic patients.
Lapolla A
Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
[No Abstract] [Full Text] [Related]
29. Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
Dysken MW; Kim SW; Vatassery G; Johnson SB; Skare S; Holden L; Thomsyck L
J Clin Psychopharmacol; 1992 Apr; 12(2):128-32. PubMed ID: 1573034
[TBL] [Abstract][Full Text] [Related]
30. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications.
Zbytovský J; Zapletálek M
Act Nerv Super (Praha); 1989 Dec; 31(4):266-7. PubMed ID: 2638106
[No Abstract] [Full Text] [Related]
32. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
Yen YC; Lung FW; Chong MY
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
[TBL] [Abstract][Full Text] [Related]
33. [Clinical trial of loxapine succinate in the treatment of 30 cases of psychotic states].
Escande M; Granier F; Gardes JP; Boscredon J; Concina M
Ann Med Psychol (Paris); 1983 Mar; 141(3):309-22. PubMed ID: 6357022
[TBL] [Abstract][Full Text] [Related]
34. A six-month follow-up of refractory chronic psychotics treated with Haldol-AID.
Wouters J
Acta Psychiatr Belg; 1978; 78(2):399-406. PubMed ID: 354327
[TBL] [Abstract][Full Text] [Related]
35. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Heikkilä L; Laitinen J; Vartiainen H
Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
[TBL] [Abstract][Full Text] [Related]
36. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
Shostak M; Perel JM; Stiller RL; Wyman W; Curran S
J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700
[TBL] [Abstract][Full Text] [Related]
37. The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate.
Leff JP; Tress KH
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():27-40. PubMed ID: 3559160
[TBL] [Abstract][Full Text] [Related]
38. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
[TBL] [Abstract][Full Text] [Related]
39. Use of bormperidol in psychotic outpatients.
Clarysse HJ
Acta Psychiatr Belg; 1978; 78(1):129-33. PubMed ID: 347875
[TBL] [Abstract][Full Text] [Related]
40. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
